MBX Biosciences Statistics
Total Valuation
MBX Biosciences has a market cap or net worth of $333.92 million. The enterprise value is $109.67 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, before market open.
Earnings Date | Nov 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MBX Biosciences has 33.59 million shares outstanding. The number of shares has increased by 2,182.51% in one year.
Current Share Class | 33.59M |
Shares Outstanding | 33.59M |
Shares Change (YoY) | +2,182.51% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | 3.14% |
Owned by Institutions (%) | 56.49% |
Float | 14.61M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.52 |
P/TBV Ratio | 1.52 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.50, with a Debt / Equity ratio of 0.00.
Current Ratio | 19.50 |
Quick Ratio | 19.20 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.28% and return on invested capital (ROIC) is -39.40%.
Return on Equity (ROE) | -56.28% |
Return on Assets (ROA) | -36.75% |
Return on Invested Capital (ROIC) | -39.40% |
Return on Capital Employed (ROCE) | -39.39% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.79M |
Employee Count | 43 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.09% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -54.09% |
50-Day Moving Average | 12.88 |
200-Day Moving Average | 12.20 |
Relative Strength Index (RSI) | 37.70 |
Average Volume (20 Days) | 349,969 |
Short Selling Information
The latest short interest is 3.84 million, so 11.44% of the outstanding shares have been sold short.
Short Interest | 3.84M |
Short Previous Month | 4.07M |
Short % of Shares Out | 11.44% |
Short % of Float | 26.31% |
Short Ratio (days to cover) | 9.76 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -86.56M |
Pretax Income | -47.20M |
Net Income | -77.02M |
EBITDA | -86.29M |
EBIT | -86.56M |
Earnings Per Share (EPS) | -$2.88 |
Full Income Statement Balance Sheet
The company has $224.91 million in cash and $650,000 in debt, giving a net cash position of $224.26 million or $6.68 per share.
Cash & Cash Equivalents | 224.91M |
Total Debt | 650,000 |
Net Cash | 224.26M |
Net Cash Per Share | $6.68 |
Equity (Book Value) | 219.24M |
Book Value Per Share | 6.53 |
Working Capital | 217.43M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$70.81 million and capital expenditures -$886,000, giving a free cash flow of -$71.70 million.
Operating Cash Flow | -70.81M |
Capital Expenditures | -886,000 |
Free Cash Flow | -71.70M |
FCF Per Share | -$2.13 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MBX Biosciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2,182.51% |
Shareholder Yield | -2,182.51% |
Earnings Yield | -23.06% |
FCF Yield | -21.47% |
Analyst Forecast
The average price target for MBX Biosciences is $37.38, which is 276.06% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $37.38 |
Price Target Difference | 276.06% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |